Choosing between bladder biopsy and tumor treatment codes

Why This Topic Matters

Bladder endoscopy cases can involve both biopsy and tumor removal, and the billing outcome depends on how the procedure is categorized and whether payer-specific rules apply. Understanding the scope of the article helps coders and revenue cycle teams identify when the full guidance is relevant to a claim.

Article Sections

1. Biopsy alone

   Discusses the general scope of bladder biopsy reporting when no separate tumor treatment is performed. The section covers broad distinctions between diagnostic and therapeutic services and references associated coding considerations.

2. Tumor treatment

   Reviews bladder tumor treatment reporting at a high level, including how lesion size and payer type relate to code selection. The section also notes that some related biopsy activity may be included in the broader procedure category.

3. Choosing between biopsy code 52204 and the TUR codes

   Summarizes the comparison framework between the biopsy and tumor treatment categories and introduces chart-based guidance. The section is focused on helping readers locate the relevant decision area in the article.